Advancements in new hepatitis C treatments

June 3, 2016

Hepatitis C is the leading blood-borne disease in the U.S., with more than 3.5 million people developing a chronic infection. While the outlook for treating hepatitis C was grim just a few years ago, now most patients can be cured with direct-acting antiviral medications, many of them evaluated at the UT Health Science Center San Antonio.


CTRC among the top 10 SWOG institutions

June 3, 2016

The Cancer Therapy & Research Center has been named among the top 10 of the 990 institutions that are members of SWOG, an international network of researchers that design and conduct cancer clinical trials.

Research team at CTRC.